Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009

David B. Hanna, Kate Buchacz, Kelly A. Gebo, Nancy A. Hessol, Michael A. Horberg, Lisa P. Jacobson, Gregory D. Kirk, Mari M. Kitahata, Philip (Todd) Korthuis, Richard D. Moore, Sonia Napravnik, Pragna Patel, Michael J. Silverberg, Timothy R. Sterling, James H. Willig, Ann Collier, Hasina Samji, Jennifer E. Thorne, Keri N. Althoff, Jeffrey N. MartinBenigno Rodriguez, Elizabeth A. Stuart, Stephen J. Gange

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: U.S. state AIDS Drug Assistance Programs (ADAPs) are federally funded to provide antiretroviral therapy (ART) as the payer of last resort to eligible persons with HIV infection. States differ regarding their financial contributions to and ways of implementing these programs, and it remains unclear how this interstate variability affects HIV treatment outcomes. Methods: We analyzed data from HIV-infected individuals who were clinically-eligible for ART between 2001 and 2009 (i.e., a first reported CD4+

Original languageEnglish (US)
Article numbere78952
JournalPLoS One
Volume8
Issue number11
DOIs
StatePublished - Nov 18 2013

Fingerprint

Anti-HIV Agents
HIV
drugs
Gift Giving
therapeutics
HIV infections
HIV Infections
Therapeutics
methodology

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Hanna, D. B., Buchacz, K., Gebo, K. A., Hessol, N. A., Horberg, M. A., Jacobson, L. P., ... Gange, S. J. (2013). Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One, 8(11), [e78952]. https://doi.org/10.1371/journal.pone.0078952

Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. / Hanna, David B.; Buchacz, Kate; Gebo, Kelly A.; Hessol, Nancy A.; Horberg, Michael A.; Jacobson, Lisa P.; Kirk, Gregory D.; Kitahata, Mari M.; Korthuis, Philip (Todd); Moore, Richard D.; Napravnik, Sonia; Patel, Pragna; Silverberg, Michael J.; Sterling, Timothy R.; Willig, James H.; Collier, Ann; Samji, Hasina; Thorne, Jennifer E.; Althoff, Keri N.; Martin, Jeffrey N.; Rodriguez, Benigno; Stuart, Elizabeth A.; Gange, Stephen J.

In: PLoS One, Vol. 8, No. 11, e78952, 18.11.2013.

Research output: Contribution to journalArticle

Hanna, DB, Buchacz, K, Gebo, KA, Hessol, NA, Horberg, MA, Jacobson, LP, Kirk, GD, Kitahata, MM, Korthuis, PT, Moore, RD, Napravnik, S, Patel, P, Silverberg, MJ, Sterling, TR, Willig, JH, Collier, A, Samji, H, Thorne, JE, Althoff, KN, Martin, JN, Rodriguez, B, Stuart, EA & Gange, SJ 2013, 'Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009', PLoS One, vol. 8, no. 11, e78952. https://doi.org/10.1371/journal.pone.0078952
Hanna, David B. ; Buchacz, Kate ; Gebo, Kelly A. ; Hessol, Nancy A. ; Horberg, Michael A. ; Jacobson, Lisa P. ; Kirk, Gregory D. ; Kitahata, Mari M. ; Korthuis, Philip (Todd) ; Moore, Richard D. ; Napravnik, Sonia ; Patel, Pragna ; Silverberg, Michael J. ; Sterling, Timothy R. ; Willig, James H. ; Collier, Ann ; Samji, Hasina ; Thorne, Jennifer E. ; Althoff, Keri N. ; Martin, Jeffrey N. ; Rodriguez, Benigno ; Stuart, Elizabeth A. ; Gange, Stephen J. / Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. In: PLoS One. 2013 ; Vol. 8, No. 11.
@article{72832804c3504c0f9ee9f280e25aed6e,
title = "Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009",
abstract = "Background: U.S. state AIDS Drug Assistance Programs (ADAPs) are federally funded to provide antiretroviral therapy (ART) as the payer of last resort to eligible persons with HIV infection. States differ regarding their financial contributions to and ways of implementing these programs, and it remains unclear how this interstate variability affects HIV treatment outcomes. Methods: We analyzed data from HIV-infected individuals who were clinically-eligible for ART between 2001 and 2009 (i.e., a first reported CD4+",
author = "Hanna, {David B.} and Kate Buchacz and Gebo, {Kelly A.} and Hessol, {Nancy A.} and Horberg, {Michael A.} and Jacobson, {Lisa P.} and Kirk, {Gregory D.} and Kitahata, {Mari M.} and Korthuis, {Philip (Todd)} and Moore, {Richard D.} and Sonia Napravnik and Pragna Patel and Silverberg, {Michael J.} and Sterling, {Timothy R.} and Willig, {James H.} and Ann Collier and Hasina Samji and Thorne, {Jennifer E.} and Althoff, {Keri N.} and Martin, {Jeffrey N.} and Benigno Rodriguez and Stuart, {Elizabeth A.} and Gange, {Stephen J.}",
year = "2013",
month = "11",
day = "18",
doi = "10.1371/journal.pone.0078952",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009

AU - Hanna, David B.

AU - Buchacz, Kate

AU - Gebo, Kelly A.

AU - Hessol, Nancy A.

AU - Horberg, Michael A.

AU - Jacobson, Lisa P.

AU - Kirk, Gregory D.

AU - Kitahata, Mari M.

AU - Korthuis, Philip (Todd)

AU - Moore, Richard D.

AU - Napravnik, Sonia

AU - Patel, Pragna

AU - Silverberg, Michael J.

AU - Sterling, Timothy R.

AU - Willig, James H.

AU - Collier, Ann

AU - Samji, Hasina

AU - Thorne, Jennifer E.

AU - Althoff, Keri N.

AU - Martin, Jeffrey N.

AU - Rodriguez, Benigno

AU - Stuart, Elizabeth A.

AU - Gange, Stephen J.

PY - 2013/11/18

Y1 - 2013/11/18

N2 - Background: U.S. state AIDS Drug Assistance Programs (ADAPs) are federally funded to provide antiretroviral therapy (ART) as the payer of last resort to eligible persons with HIV infection. States differ regarding their financial contributions to and ways of implementing these programs, and it remains unclear how this interstate variability affects HIV treatment outcomes. Methods: We analyzed data from HIV-infected individuals who were clinically-eligible for ART between 2001 and 2009 (i.e., a first reported CD4+

AB - Background: U.S. state AIDS Drug Assistance Programs (ADAPs) are federally funded to provide antiretroviral therapy (ART) as the payer of last resort to eligible persons with HIV infection. States differ regarding their financial contributions to and ways of implementing these programs, and it remains unclear how this interstate variability affects HIV treatment outcomes. Methods: We analyzed data from HIV-infected individuals who were clinically-eligible for ART between 2001 and 2009 (i.e., a first reported CD4+

UR - http://www.scopus.com/inward/record.url?scp=84894146769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894146769&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0078952

DO - 10.1371/journal.pone.0078952

M3 - Article

C2 - 24260137

AN - SCOPUS:84894146769

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e78952

ER -